<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<HTML><HEAD><TITLE>Molecular Cloning | Protocol 4 Print Version</TITLE>
<META http-equiv=Content-Type content="text/html; charset=windows-1251"><!--================== Designed and Developed by WriteDesign =================--><!--======================= Powered by RomeBlack, Inc. =======================--><!--=== Copyright 2000, 2001 Cold Spring Harbor Labs. All Rights Reserved. ===-->
<META content="" name=keywords>
<META 
content="Incubation of a blunt-end ligation reaction in the presence of an excess amount of an appropriate restriction enzyme can dramatically increase the yield of recombinant plasmids. The role of the restriction enzyme is to cleave circular and linear concatemers at restriction sites that are re-formed when linear, blunt-ended plasmid molecules ligate to themselves. In almost all cases, ligation of the PCR product to the plasmid destroys the restriction site. The constant reclamation of vector molecules drives the equilibrium of the ligation reaction strongly in favor of the recombinants between vector and blunt-ended PCR product." 
name=description>
<META content="MSHTML 5.50.4134.600" name=GENERATOR></HEAD>
<BODY bgColor=#ffffff background=../izo/fon.gif>
<table width=600 border="0" cellspacing="0" cellpadding="0"><tr><td width=600><IMG height=49 hspace=4 src="../izo/logo_csh.gif" 
width=169 align=left vspace=4><IMG height=49 hspace=4 
src="../izo/print_header.gif" width=293 align=left vspace=4><BR 
clear=all><BR><FONT face="arial,verdana, helvetica" size=4><STRONG>Chapter 8, 
Protocol 4</STRONG></FONT><BR><BR clear=all><FONT face=arial,verdana,helvetica 
size=3><STRONG>Blunt-end Cloning of PCR Products</STRONG></FONT><BR><BR><FONT 
face="arial,verdana, helvetica" size=2>Incubation of a blunt-end ligation 
reaction in the presence of an excess amount of an appropriate restriction 
enzyme can dramatically increase the yield of recombinant plasmids. The role of 
the restriction enzyme is to cleave circular and linear concatemers at 
restriction sites that are re-formed when linear, blunt-ended plasmid molecules 
ligate to themselves. In almost all cases, ligation of the PCR product to the 
plasmid destroys the restriction site. The constant reclamation of vector 
molecules drives the equilibrium of the ligation reaction strongly in favor of 
the recombinants between vector and blunt-ended PCR product.</FONT> <BR><BR>
<TABLE border=1>
  <TBODY>
  <TR>
    <TD width=700><IMG height=11 alt=CSH hspace=4 src="../izo/triangle.gif" 
      width=11 border=0><FONT face=arial,verdana,helvetica 
      size=2><STRONG>CAUTION</STRONG></FONT><BR><IMG height=12 alt="" hspace=4 
      src="../izo/circle.gif" width=12 border=0><FONT 
      face="arial,verdana, helvetica" size=2> <STRONG>RECIPE</STRONG></FONT> 
  </TD></TR></TBODY></TABLE><BR><BR><FONT face=arial,verdana,helvetica 
size=3><STRONG>MATERIALS</STRONG></FONT><BR><BR>
<TABLE cellPadding=0 cellborder="0">
  <TBODY>
  <TR>
    <TD vAlign=top align=left><FONT face="arial,verdana, helvetica" 
      size=2><STRONG>Buffers and Solutions</STRONG></FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>ATP (10 
      mM)</FONT> <IMG height=11 alt=caution hspace=4 src="../izo/triangle.gif" 
      width=12 border=0><IMG height=12 alt="" hspace=4 src="../izo/circle.gif" 
      width=12 border=0> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>dNTP solution 
      (2 mM) containing all four dNTPs</FONT> <IMG height=12 alt="" hspace=4 
      src="../izo/circle.gif" width=12 border=0> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>10x Universal 
      KGB buffer</FONT> <IMG height=12 alt="" hspace=4 src="../izo/circle.gif" 
      width=12 border=0> </TD></TR>
  <TR>
    <TD><IMG height=10 src="../izo/spacer.gif" width=1 border=0></TD></TR>
  <TR>
    <TD vAlign=top align=left><FONT face="arial,verdana, helvetica" 
      size=2><STRONG>Enzymes and Buffers</STRONG></FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>Bacteriophage 
      T4 DNA ligase</FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>Bacteriophage 
      T4 DNA polymerase</FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2><I>Do not use 
      the Klenow fragment of </I>E. coli <I>DNA polymerase.</I></FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>Restriction 
      endonuclease for cloning </FONT></TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2><I>The 
      restriction enzyme should generate blunt ends, cleave the vector once, and 
      <I>not</I> cleave the amplified DNA (please see Step 1).</I></FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>Restriction 
      endonucleases</FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2><I>Please see 
      Step 4.</I></FONT> </TD></TR>
  <TR>
    <TD><IMG height=10 src="../izo/spacer.gif" width=1 border=0></TD></TR>
  <TR>
    <TD vAlign=top align=left><FONT face="arial,verdana, helvetica" 
      size=2><STRONG>Nucleic Acids and Oligonucleotides</STRONG></FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>Closed 
      circular plasmid DNA (50 µg/ml)</FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2><I>Choose a 
      plasmid vector containing a single site for a restriction enzyme that 
      generates blunt ends (e.g., </I>Sma<I>I</I>, Srf<I>I, and </I>Eco<I>RV). 
      The plasmid vector and its bacterial host should carry a blue/white 
      screening system.</I></FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>Target DNA (25 
      µg/ml), amplified by PCR.</FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2><I>When the 
      PCR mixture contains more than one or two bands of amplified DNA, purify 
      the target fragment by electrophoresis through low melting/gelling 
      temperature agarose (please see <A href="../05/06.htm">Chapter 
      5, Protocol 6 </A>). If not purified by gel electrophoresis, PCR-amplified 
      DNA should be prepared for ligation by extraction with phenol:chloroform 
      and ultrafiltration through a Centricon-100 filter (please see <A href="03.htm">Chapter 
      8, Protocol 3 </A>).</I></FONT> </TD></TR>
  <TR>
    <TD><IMG height=10 src="../izo/spacer.gif" width=1 border=0></TD></TR>
  <TR>
    <TD vAlign=top align=left><FONT face="arial,verdana, helvetica" 
      size=2><STRONG>Additional Reagents</STRONG></FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>Step 3 of this 
      protocol requires the reagents listed in <A href="../01/25.htm">Chapter 
      1, Protocol 25 </A>or <A href="../01/26.htm">Chapter 
      1, Protocol 26 </A>and <A href="../01/27.htm">Chapter 
      1, Protocol 27 </A></FONT></TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>Step 4 of this 
      protocol may require the reagents listed in <A href="12.htm">Chapter 
      8, Protocol 12 </A>.</FONT> </TD></TR>
  <TR>
    <TD vAlign=top><FONT face="arial,verdana, helvetica" size=2>Step 6 of this 
      protocol requires the reagents listed in <A href="../12/06.htm">Chapter 
      12, Protocol 6 </A>or <A href="../06/10.htm">Chapter 
      6, Protocol 10 </A>.</FONT> </TD></TR>
  <TR>
    <TD><IMG height=10 src="../izo/spacer.gif" width=1 
  border=0></TD></TR></TBODY></TABLE><BR><BR><FONT 
face="arial,verdana,&#13;&#10;    helvetica" 
size=3><STRONG>METHOD</STRONG></FONT> <BR><FONT face="arial,verdana, helvetica" 
color=#000000 size=2>
<OL>
  <LI><FONT face="arial,verdana, helvetica" color=#000000 size=2>In a microfuge 
  tube, mix the following in the order shown: 
  <TABLE>
    <TBODY>
    <TR>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>50 µg/ml closed 
        circular plasmid vector</FONT></TD>
      <TD width=5></FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>1 
    µl</FONT></TD></TR>
    <TR>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>25 µg/ml 
        amplified target DNA</FONT></TD>
      <TD width=5></FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>8 
    µl</FONT></TD></TR>
    <TR>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>10x universal 
        KGB buffer</FONT></TD>
      <TD width=5></FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>2 
    µl</FONT></TD></TR>
    <TR>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>H<SUB>2</SUB>O 
        (please see note below)</FONT></TD>
      <TD width=5></FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>5 
    µl</FONT></TD></TR>
    <TR>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>10 mM 
      ATP</FONT></TD>
      <TD width=5></FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>1 
    µl</FONT></TD></TR>
    <TR>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>2 mM 
        dNTPs</FONT></TD>
      <TD width=5></FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>1 
    µl</FONT></TD></TR>
    <TR>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>restriction 
        enzyme</FONT></TD>
      <TD width=5></FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>2 
      units</FONT></TD></TR>
    <TR>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>T4 DNA 
        polymerase</FONT></TD>
      <TD width=5></FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>1 
    unit</FONT></TD></TR>
    <TR>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>T4 DNA 
        ligase</FONT></TD>
      <TD width=5></FONT></TD>
      <TD vAlign=top><FONT face=arial,verdana,helvetica size=2>3 
      units</FONT></TD></TR></TBODY></TABLE><I>Adjust the amount of H<SUB>2</SUB>O 
  added so that the final reaction volume is 20</I> µl.<BR>Set up a control 
  reaction that contains all of the reagents listed above except the amplified 
  target DNA. </FONT>
  <LI><FONT face="arial,verdana, helvetica" color=#000000 size=2>Incubate the 
  ligation mixture for 4 hours at 22°C. </FONT>
  <LI><FONT face="arial,verdana, helvetica" color=#000000 size=2>Dilute 5 µl of 
  each of the two ligation mixtures with 10 µl of H<SUB>2</SUB>O and transform a 
  suitable strain of competent <I>E. coli</I> to antibiotic resistance as 
  described in <A href="../01/25.htm">Chapter 
  1, Protocol 25 </A>or <A href="../01/26.htm">Chapter 
  1, Protocol 26 </A>. Plate the transformed cultures on media containing IPTG 
  and X-gal (please see <A href="../01/27.htm">Chapter 
  1, Protocol 27 </A>) and the appropriate antibiotic. </FONT>
  <LI><FONT face="arial,verdana, helvetica" color=#000000 size=2>Calculate the 
  number of colonies obtained from each of the ligation mixtures. Pick a number 
  of white colonies obtained by transformation with the ligation reaction 
  containing the target DNA. Confirm the presence of the amplified fragment by 
  (i) isolating the plasmid DNAs and digesting them with restriction enzymes 
  whose sites flank the insert in the multiple cloning site or (ii) colony PCR 
  (<A href="12.htm">Chapter 
  8, Protocol 12 </A>). </FONT>
  <LI><FONT face="arial,verdana, helvetica" color=#000000 size=2>Fractionate the 
  restricted DNA by electrophoresis through an agarose gel using appropriate DNA 
  size markers. Measure the size of the cloned fragments. </FONT>
  <LI><FONT face="arial,verdana, helvetica" color=#000000 size=2>Confirm the 
  identity of the cloned fragments by DNA sequencing, restriction mapping, or 
  Southern hybridization. </FONT></LI></OL></FONT><BR><BR><FONT 
face="arial,verdana,&#13;&#10;    helvetica" size=3><STRONG>RECIPES</STRONG> 
</FONT><IMG height=11 alt=CSH hspace=4 src="../izo/circle.gif" width=12 
border=0> <BR><BR>
<TABLE border=0>
  <TBODY>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD vAlign=top align=left width=400><FONT face=arial,verdana,helvetica 
      color=#000000 size=2><STRONG>ATP</STRONG></FONT> </TD></TR>
  <TR>
    <TD><IMG height=12 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>
      <P>Dissolve an appropriate amount of solid ATP in 25 mM Tris-Cl (pH 
      8.0).</P>
      <P>Store the 10 mM ATP solution in small aliquots at 
  -20°C.</P></FONT></TD></TR></TBODY></TABLE><BR>
<TABLE border=0>
  <TBODY>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD vAlign=top align=left width=400><FONT face=arial,verdana,helvetica 
      color=#000000 size=2><STRONG>Potassium Acetate</STRONG></FONT> </TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>5 M potassium acetate, 60 
      ml</FONT></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>glacial acetic acid, 11.5 
      ml</FONT></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>H<SUB>2</SUB>O, 28.5 
      ml</FONT></TD></TR>
  <TR>
    <TD><IMG height=12 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>The resulting solution is 
      3 M with respect to potassium and 5 M with respect to acetate. Store the 
      buffer at room temperature.</FONT></TD></TR></TBODY></TABLE><BR>
<TABLE border=0>
  <TBODY>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD vAlign=top align=left width=400><FONT face=arial,verdana,helvetica 
      color=#000000 size=2><STRONG>Universal KGB Buffer</STRONG></FONT> </TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>1 M potassium 
      acetate</FONT></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>250 mM Tris-acetate (pH 
      7.6)</FONT></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>100 mM magnesium acetate 
      tetrahydrate</FONT></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>5 mM <IMG 
      src="../izo/beta.gif" border=0>-mercaptoethanol</FONT></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>0.1 mg/ml bovine serum 
      albumin</FONT></TD></TR>
  <TR>
    <TD><IMG height=12 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>Store the 10x restriction 
      endonuclease buffer in aliquots at -20°C.</FONT></TD></TR></TBODY></TABLE><BR>
<TABLE border=0>
  <TBODY>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD vAlign=top align=left width=400><FONT face=arial,verdana,helvetica 
      color=#000000 size=2><STRONG>dNTP Solution</STRONG></FONT> </TD></TR>
  <TR>
    <TD><IMG height=12 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD><FONT face="arial,verdana, helvetica" size=2>
      <P>Dissolve each dNTP (deoxyribonucleoside triphosphates) in 
      H<SUB>2</SUB>O at an approximate concentration of 100 mM. Use 0.05 M Tris 
      base and a micropipette to adjust the pH of each of the solutions to 7.0 
      (use pH paper to check the pH). Dilute an aliquot of the neutralized dNTP 
      appropriately, and read the optical density at the wavelengths given in 
      the table below. Calculate the actual concentration of each dNTP. Dilute 
      the solutions with H<SUB>2</SUB>O to a final concentration of 50 mM dNTP. 
      Store each separately at -70°C in small aliquots. For polymerase chain 
      reactions (PCRs), adjust the dNTP solution to pH 8.0 with 2 N NaOH. 
      Commercially available solutions of PCR-grade dNTPs require no 
      adjustment.</P>
      <P>
      <TABLE width=400>
        <TBODY>
        <TR>
          <TD><FONT face=arial,helvetica,verdana size=2>Base</FONT></TD>
          <TD><FONT face=arial,helvetica,verdana 
            size=2>wavelength<BR>(nm)</FONT></TD>
          <TD><FONT face=arial,helvetica,verdana size=2>Extinction 
            Coefficient<BR>(E)&nbsp;(M<SUP>-1</SUP>cm<SUP>-1</SUP>)</FONT></TD></TR>
        <TR>
          <TD><FONT face=arial,helvetica,verdana size=2>A</FONT></TD>
          <TD><FONT face=arial,helvetica,verdana size=2>259</FONT></TD>
          <TD><FONT face=arial,helvetica,verdana size=2>1.54 x 
            10<SUP>4</SUP></FONT></TD></TR>
        <TR>
          <TD><FONT face=arial,helvetica,verdana size=2>G</FONT></TD>
          <TD><FONT face=arial,helvetica,verdana size=2>253</FONT></TD>
          <TD><FONT face=arial,helvetica,verdana size=2>1.37 x 
            10<SUP>4</SUP></FONT></TD></TR>
        <TR>
          <TD><FONT face=arial,helvetica,verdana size=2>C</FONT></TD>
          <TD><FONT face=arial,helvetica,verdana size=2>271</FONT></TD>
          <TD><FONT face=arial,helvetica,verdana size=2>9.10 x 
            10<SUP>3</SUP></FONT></TD></TR>
        <TR>
          <TD><FONT face=arial,helvetica,verdana size=2>T</FONT></TD>
          <TD><FONT face=arial,helvetica,verdana size=2>267</FONT></TD>
          <TD><FONT face=arial,helvetica,verdana size=2>9.60 x 
            10<SUP>3</SUP></FONT></TD></TR></TBODY></TABLE></P>
      <P>For a cuvette with a path length of 1 cm, absorbance = EM. 100 mM stock 
      solutions of each dNTP are commercially available 
    (Pharmacia).</P></FONT></TD></TR></TBODY></TABLE><BR><BR><BR><FONT 
face="arial,verdana,&#13;&#10;     helvetica" size=3><STRONG>CAUTIONS</STRONG> 
</FONT><IMG height=11 alt=CSH hspace=4 src="../izo/triangle.gif" width=11 
border=0> <BR><BR>
<TABLE border=0>
  <TBODY>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD vAlign=top align=left><FONT face=arial,verdana,helvetica color=#000000 
      size=2><STRONG>&szlig;-Mercaptoethanol </STRONG></FONT></TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD vAlign=top align=left><FONT face="arial,verdana, helvetica" size=2 
      font="">&szlig;-Mercaptoethanol (2-Mercaptoethanol) 
      HOCH<SUB>2</SUB>CH<SUB>2</SUB>SH may be fatal if inhaled or absorbed 
      through the skin and is harmful if ingested. High concentrations are 
      extremely destructive to the mucous membranes, upper respiratory tract, 
      skin, and eyes. &szlig;-Mercaptoethanol has a very foul odor. Wear appropriate 
      gloves and safety glasses. Always use in a chemical fume hood. 
  </FONT></TD></TR></TBODY></TABLE><BR>
<TABLE border=0>
  <TBODY>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD vAlign=top align=left><FONT face=arial,verdana,helvetica color=#000000 
      size=2><STRONG>Glacial acetic acid</STRONG></FONT> </TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD vAlign=top align=left><FONT face="arial,verdana, helvetica" size=2 
      font="">Acetic acid (concentrated) must be handled with great care. It may 
      be harmful by inhalation, ingestion, or skin absorption. Wear appropriate 
      gloves and goggles. Use in a chemical fume hood. 
</FONT></TD></TR></TBODY></TABLE><BR>
<TABLE border=0>
  <TBODY>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD vAlign=top align=left><FONT face=arial,verdana,helvetica color=#000000 
      size=2><STRONG>Radioactive substances</STRONG></FONT> </TD></TR>
  <TR>
    <TD><IMG height=1 src="../izo/spacer.gif" width=40 border=0></TD>
    <TD vAlign=top align=left><FONT face="arial,verdana, helvetica" size=2 
      font="">Radioactive substances: When planning an experiment that involves 
      the use of radioactivity, consider the physico-chemical properties of the 
      isotope (half-life, emission type, and energy), the chemical form of the 
      radioactivity, its radioactive concentration (specific activity), total 
      amount, and its chemical concentration. Order and use only as much as 
      needed. Always wear appropriate gloves, lab coat, and safety goggles when 
      handling radioactive material. X-rays and gamma rays are electromagnetic 
      waves of very short wavelengths either generated by technical devices or 
      emitted by radioactive materials. They might be emitted isotropically from 
      the source or may be focused into a beam. Their potential dangers depend 
      on the time period of exposure, the intensity experienced, and the 
      wavelengths used. Be aware that appropriate shielding is usually made of 
      lead or other similar material. The thickness of the shielding is 
      determined by the energy(s) of the X-rays or gamma rays. Consult the local 
      safety office for further guidance in the appropriate use and disposal of 
      radioactive materials. Always monitor thoroughly after using 
      radioisotopes. A convenient calculator to perform routine radioactivity 
      calculations can be found at: <A target=_blank 
      href="http://www.graphpad.com/calculators/radcalc.cfm">http://www.graphpad.com/calculators/radcalc.cfm</A>. 
      </FONT></TD></TR></TBODY></TABLE><BR><BR><BR><FONT 
face="arial,verdana,&#13;&#10;    helvetica" size=3><STRONG>REFERENCES</STRONG> 
</FONT><BR>
<OL>
  <LI><FONT face="arial,verdana, helvetica" color=#000000 size=2>Chuang S.E., 
  Wang K.C., and Cheng A.L. 1995. Single-step direct cloning of PCR products. 
  <I>Trends Genet</I> 11:7-8. </FONT>
  <LI><FONT face="arial,verdana, helvetica" color=#000000 size=2>Liu Z.G. and 
  Schwartz L.M. 1992. An efficient method for blunt-end ligation of PCR 
  products. <I>BioTechniques</I> 12:28-30. </FONT>
  <LI><FONT face="arial,verdana, helvetica" color=#000000 size=2>Weiner M.P. 
  1993. Directional cloning of blunt-ended PCR products. <I>BioTechniques</I> 
  15:502-505. </FONT></LI></OL><BR><BR><BR><BR><BR><FONT 
face=Arial,Verdana,Helvetica size=1><STRONG>Copyright © 2000 by Cold Spring 
Harbor Laboratory Press. All rights reserved.</STRONG><BR>No part of these 
pages, either text or image may be used for any purpose other than personal use. 
Therefore, reproduction modification, storage in a retrieval system or 
retransmission, in any form or by any means, electronic, mechanical, or 
otherwise, for reasons other than personal use, is strictly prohibited without 
prior written permission.</FONT><BR><BR>
</td></tr></table>
</BODY></HTML>
